Oren Shuster's guest appearances

Oren Shuster

The Cannabis Investing Podcast

GritCast Podcast

The Exchange for Entrepreneurs™ Podcast 

Chris Driessen

Chuck Smith

Alan Brochstein

Brad Moore

Bruce Linton

Kim Rivers

Steve White

Vitaliy Katsenelson

Howie Mandel

Bruce Campbell

Andrew Berman

Kevin Murphy

Debra Borchardt

Peter Miller

Julian Lin

OwlTail

I talked to Oren Shuster, CEO of IM Cannabis, this week in Tel Aviv at its CannaBIZ conference. We discuss the significant share price decline in the industry across the board; the significance of the Republican announcement in the US. Israel's unique market, comparisons to Michigan; Germany and Europe and the growth still to come.Learn more about your ad choices. Visit megaphone.fm/adchoices

I talked to Oren Shuster, CEO of IM Cannabis, this week in Tel Aviv at its CannaBIZ conference. We discuss the significant share price decline in the industry across the board; the significance of the Republican announcement in the US. Israel's unique market, comparisons to Michigan; Germany and Europe and the growth still to come. Learn more about your ad choices. Visit <a href="http://megaphone.fm/adchoices" rel="nofollow" target="_blank">megaphone.fm/adchoices</a>

IM Cannabis CEO Oren Shuster - Multi-Country Operator

Oren Shuster, CEO of IM Cannabis Corp. (CSE:IMCC), joined Barrington Miller in the podcast studio to share how the company's foundation has been built on the experience of growing pharma-grade cannabis since 2010 (3:21), their focus on applying EU GMP standards to meet growing demand in Europe (5:13), and the important lessons learned through trial and error over the years (8:12). Listen until the end to learn more about the distinct differences between the EU/Israeli market vis-à-vis North America and the opportunity presented by the German medical cannabis market. 

Oren Shuster, CEO of IM Cannabis Corp. (CSE:IMCC), joined Barrington Miller in the podcast studio to share how the company's foundation has been built on the experience of growing pharma-grade cannabis since 2010 (3:21), their focus on applying EU GMP standards to meet growing demand in Europe (5:13), and the important lessons learned through trial and error over the years (8:12). Listen until the end to learn more about the distinct differences between the EU/Israeli market vis-à-vis North America and the opportunity presented by the German medical cannabis market.

Oren Shuster on Serving the Medical Cannabis Market in Europe | #HashtagFinance